Alpha Tau Medical (DRTS) Competitors $3.05 +0.03 (+0.99%) As of 02:55 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock DRTS vs. PLSE, BLFS, TNDM, MDXG, INMD, KMTS, IRMD, SIBN, BBNX, and EMBCShould you be buying Alpha Tau Medical stock or one of its competitors? The main competitors of Alpha Tau Medical include Pulse Biosciences (PLSE), BioLife Solutions (BLFS), Tandem Diabetes Care (TNDM), MiMedx Group (MDXG), InMode (INMD), Kestra Medical Technologies (KMTS), iRadimed (IRMD), SiBone (SIBN), Beta Bionics (BBNX), and Embecta (EMBC). These companies are all part of the "medical equipment" industry. Alpha Tau Medical vs. Its Competitors Pulse Biosciences BioLife Solutions Tandem Diabetes Care MiMedx Group InMode Kestra Medical Technologies iRadimed SiBone Beta Bionics Embecta Alpha Tau Medical (NASDAQ:DRTS) and Pulse Biosciences (NASDAQ:PLSE) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their valuation, earnings, analyst recommendations, institutional ownership, dividends, profitability, media sentiment and risk. Do institutionals & insiders hold more shares of DRTS or PLSE? 2.7% of Alpha Tau Medical shares are held by institutional investors. Comparatively, 76.9% of Pulse Biosciences shares are held by institutional investors. 39.5% of Alpha Tau Medical shares are held by insiders. Comparatively, 71.5% of Pulse Biosciences shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term. Does the media favor DRTS or PLSE? In the previous week, Alpha Tau Medical and Alpha Tau Medical both had 1 articles in the media. Pulse Biosciences' average media sentiment score of 1.87 beat Alpha Tau Medical's score of 0.94 indicating that Pulse Biosciences is being referred to more favorably in the news media. Company Overall Sentiment Alpha Tau Medical Positive Pulse Biosciences Very Positive Is DRTS or PLSE more profitable? Alpha Tau Medical's return on equity of -49.48% beat Pulse Biosciences' return on equity.Company Net Margins Return on Equity Return on Assets Alpha Tau MedicalN/A -49.48% -36.69% Pulse Biosciences N/A -68.44%-58.17% Which has preferable valuation & earnings, DRTS or PLSE? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAlpha Tau MedicalN/AN/A-$31.75M-$0.46-6.63Pulse BiosciencesN/AN/A-$53.58MN/AN/A Which has more volatility & risk, DRTS or PLSE? Alpha Tau Medical has a beta of 0.99, meaning that its share price is 1% less volatile than the S&P 500. Comparatively, Pulse Biosciences has a beta of 1.56, meaning that its share price is 56% more volatile than the S&P 500. Do analysts rate DRTS or PLSE? Alpha Tau Medical presently has a consensus target price of $8.00, indicating a potential upside of 162.30%. Pulse Biosciences has a consensus target price of $22.00, indicating a potential upside of 49.00%. Given Alpha Tau Medical's higher probable upside, equities analysts clearly believe Alpha Tau Medical is more favorable than Pulse Biosciences.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Alpha Tau Medical 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00Pulse Biosciences 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 SummaryAlpha Tau Medical beats Pulse Biosciences on 5 of the 9 factors compared between the two stocks. Get Alpha Tau Medical News Delivered to You Automatically Sign up to receive the latest news and ratings for DRTS and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding DRTS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart DRTS vs. The Competition Export to ExcelMetricAlpha Tau MedicalMED INSTRUMENTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$258.70M$6.98B$5.71B$9.51BDividend YieldN/A1.28%4.60%3.99%P/E Ratio-6.6325.4128.0720.02Price / SalesN/A46.77459.47103.02Price / CashN/A20.6736.5558.97Price / Book3.434.738.615.88Net Income-$31.75M$176.14M$3.24B$258.50M7 Day Performance0.33%2.59%3.83%2.03%1 Month Performance2.18%3.25%10.40%12.52%1 Year Performance43.53%7.18%34.13%19.07% Alpha Tau Medical Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)DRTSAlpha Tau Medical2.8696 of 5 stars$3.05+1.0%$8.00+162.3%+43.8%$258.70MN/A-6.6380Positive NewsPLSEPulse Biosciences3.9584 of 5 stars$14.97-0.9%$22.00+47.0%-18.9%$1.02B$700K0.00140Positive NewsBLFSBioLife Solutions2.2726 of 5 stars$20.76-0.3%$31.17+50.1%-0.4%$996.41M$82.25M-71.58440News CoveragePositive NewsAnalyst ForecastTNDMTandem Diabetes Care4.2498 of 5 stars$14.63-0.9%$32.71+123.6%-63.7%$983.79M$940.20M-5.262,650Positive NewsMDXGMiMedx Group3.4061 of 5 stars$6.65+3.6%$11.50+72.9%-7.2%$948.25M$348.88M24.63870Positive NewsUpcoming EarningsINMDInMode3.779 of 5 stars$13.96+0.4%$18.54+32.8%-17.9%$878.29M$394.82M8.85480Upcoming EarningsKMTSKestra Medical TechnologiesN/A$16.63+4.6%$27.33+64.4%N/A$816.44M$59.81M0.00300IRMDiRadimed4.9269 of 5 stars$56.19-0.9%$72.00+28.1%+18.0%$720.81M$75.15M36.25110Upcoming EarningsSIBNSiBone4.0617 of 5 stars$16.67+0.3%$22.50+35.0%+5.7%$708.25M$167.18M-26.05350News CoverageBBNXBeta BionicsN/A$14.30+5.2%$23.44+63.9%N/A$589.21M$65.12M0.00294News CoverageLockup ExpirationEMBCEmbecta4.6859 of 5 stars$10.29+5.2%$19.00+84.6%-30.4%$571.57M$1.12B11.432,100 Related Companies and Tools Related Companies PLSE Alternatives BLFS Alternatives TNDM Alternatives MDXG Alternatives INMD Alternatives KMTS Alternatives IRMD Alternatives SIBN Alternatives BBNX Alternatives EMBC Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:DRTS) was last updated on 7/25/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredTrump’s betrayal exposed Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredTreasury Secretary Bessent Is Betting Big on GoldWhen the U.S. Treasury Secretary’s largest personal investment is gold — that’s a signal. Now a veteran gol...Golden Portfolio | SponsoredYour blueprint for crypto wealthMark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Alpha Tau Medical Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Alpha Tau Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
